Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates
Titel:
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates
Auteur:
Gianolio, Diego A. Rouleau, Cecile Bauta, William E. Lovett, Dennis Cantrell, William R. Recio, Antonio Wolstenholme-Hogg, Paul Busch, Michelle Pan, Peng Stefano, James E. Kramer, Hildegard M. Goebel, James Krumbholz, Roy D. Roth, Stephanie Schmid, Steven M. Teicher, Beverly A.